Scanning The Human Genome Provide Insights Into The Likelihood Of Future Disease

Scanning The Human Genome Provide Insights Into The Likelihood Of Future Disease.
Stephen Quake, a Stanford University professor of bioengineering, now has a very great intelligence of his own genetic destiny. Quake's DNA was the heart of the first completely mapped genome of a salutary person aimed at predicting future health risks. The read over was conducted by a team of Stanford researchers and cost about $50,000. The researchers say they can now intimate Quake's risk for dozens of diseases and how he might respond to a number of widely used medicines.

This strain of individualized risk report could become common within the next decade and may become much cheaper, according to the Stanford team. "The $1000 genome trial is coming fast. The challenge lies in knowing what to do with all that information. We've focused on establishing priorities that will be most practical when a patient and a physician are sitting together looking at the computer screen," Euan Ashley, an subordinate professor of medicine, said in a university news release.

Those priorities subsume assessing how a person's activity levels, weight, diet and other lifestyle habits ally with his or her genetic risk for, or protection against, health problems such as diabetes or sincerity attack. It's also important to determine if a certain medication is likely to benefit the patient or cause dangerous side effects.

"We're at the dawn of a new age in genomics. Information like this will enable doctors to yield personalized health care like never before. Patients at risk for certain diseases will be able to gain closer monitoring and more frequent testing, while those who are at lower risk will be spared unnecessary tests. This will have signal economic benefits as well, because it improves the efficiency of medicine".

The Gene Responsible For Alzheimer's Disease

The Gene Responsible For Alzheimer's Disease.
Data that details every gene in the DNA of 410 settle with Alzheimer's plague can now be studied by researchers, the US National Institutes of Health announced this week. This leading batch of genetic data is now available from the Alzheimer's Disease Sequencing Project, launched in February 2012 as portion of an intensified national application to find ways to prevent and treat Alzheimer's disease. Genome sequencing outlines the instruction of all 3 billion chemical letters in an individual's DNA, which is the entire set of genetic data every individual carries in every cell.

And "Providing raw DNA sequence data to a wide range of researchers is a powerful, crowd-sourced mode to find genomic changes that put us at increased risk for this devastating disease," NIH Director Dr Francis Collins said in an introduce news release. "The genome launch is designed to identify genetic risks for late onset of Alzheimer's disease, but it could also perceive versions of genes that protect us," Collins said.